marijuana stock news

Leafbuyer Technologies, Inc. Reports Substantial Growth in Oklahoma

 Leafbuyer Technologies, Inc. (“Leafbuyer” or “the Company”) (LBUY), a leading cannabis technology platform, announced today its booked sales in Oklahoma has seen a 43% increase for the quarter ending June 30, 2020 compared to the previous quarter.

“We’re extremely pleased with the success in Oklahoma and we will continue to focus our marketing and sales efforts toward our texting, loyalty, and online ordering platforms,” said Kurt Rossner, CEO of Leafbuyer. “This progress provides huge momentum and sets a solid foundation for the remainder of 2020.”

As Oklahoma medical marijuana sales skyrocket, the Company continues to diversify its revenue streams through the advancement of its technology solutions and through executing its emerging market strategies.

“The development of our technologies along with increased texting and loyalty sales account for our quarter over quarter success,” stated Rossner. “With over 2000 dispensary licenses in the state of Oklahoma, it is important we establish market share and offer the highest-quality technology solutions in the industry.”

Leafbuyer realizes revenue from the sales of its texting and loyalty application, online ordering platform, and access to millions of cannabis consumers through the Leafbuyer.com website and its network partners.

About Leafbuyer Technologies, Inc.

Leafbuyer Technologies is one of the most comprehensive technology and communication software providers for the cannabis industry. Leafbuyer.com is an all-inclusive online resource for cannabis deals and information. Leafbuyer works alongside businesses to showcase their unique products and build a network of loyal patrons. Leafbuyer’s national network of cannabis deals and information reaches millions of consumers every month. Leafbuyer is the official cannabis deals platform of Dope Media, Sensi Magazine, and Voice Media Group.

Learn more at Leafbuyer.com

CONTACTS:

Leafbuyer Technologies, Inc.
Andre Leonard
+720-432-5593
aleonard@leafbuyer.com

Cautionary Statement Regarding Forward-Looking Information

Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in the forward-looking statements due to several factors detailed from time to time in our filings with the Securities and Exchange Commission. Reference is hereby made to cautionary statements set forth in the Company’s most recent SEC filings.

SOURCE: Leafbuyer Technologies, Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

MustGrow Biologics Corp. (MGROF) to Present at the Harbor Access Global SMID Cap Investor Conference November 16th

MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference…

Premier Health Group Inc. (PHGI) (PHGRF) Announces Closing of Cloud Practice Inc. Acquisition

Premier Health Announces Closing of Cloud Practice Inc. Acquisition Cloud Practice Inc.,…

$FSF at Kentucky Department of Agriculture Industrial Hemp Pilot Project Press Event

Freedom Seed and Feed COO Michael Lewis to speak at Kentucky Department…

 Tetra Bio-Pharma Inc. (TBPMF) Announces Plenitude Clinical Trial is Initiated

Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated Tetra Bio-Pharma Inc. (“Tetra”…